Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Oct 01 2025

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated October 01, 2025, titled "Sentynl Therapeutics updates on its NDA for CUTX-101".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases